ITOS Archived Articles
iTeos Therapeutics (ITOS): A Promising Biotech Navigating the Immuno-Oncology Landscape
Published on November 30, 2024
iTeos Therapeutics, Inc. (NASDAQ:ITOS): A Promising Immuno-Oncology Player Advancing Novel Therapies
Published on September 24, 2024